WHAT IS CTC?
The overarching aim of the Clinical Translational Catalyst (CTC) is to provide a platform to transform Hong Kong and Greater Bay Area to become the go-to destination for translational medicine in the region. Under this programme, funding support will be provided to biomedical companies of HKSTP to bring innovative, life-changing therapies and technologies to patients. In addition, a professional network of key stakeholders such as principal investigators from teaching hospitals, clinical trial units, academia and investors will be engaged to work together to turn research into practical products for patients.
If your company has a highly promising project at the pre-clinical/clinical stage, the CTC team will work with you to catalyse its development towards attaining regulatory approvals for clinical trials, conducting clinical trials and achieving commercialisation.
WHAT WILL CTC GIVE YOU?
Professional & Network Support
- Learn about the latest regulatory updates via webinars and workshops
- Connect with professionals to understand the regulatory approval and clinical trial processes
- Establish your network of principal investigators, technical experts and commercial partners (e.g. CROs, CDMOs and CMOs)
ASK CTC! is a specialized HELPDESK specifically designed to help biotech companies kick-start their translational journey towards regulatory submissions and clinical trials (ASK CTC! and See Our Upcoming Events).
Financial Support for Regulatory Affairs
- Access up to HK$4 million, to subsidise 50% of the expenditure for preclinical/nonclinical activities that support the regulatory submissions of therapeutics.
- Access up to HK$2.5 million for Class III medical devices, HK$1million for de novo medical devices and HK$0.5 million for Class II medical devices, to subsidise 50% of the expenditure for preclinical/nonclinical activities that support the regulatory submissions of medical devices.
Financial Support for Clinical Trials
- Access up to HK$8 million, to subsidise 50% of expenditure for Phase I/II clinical trials of therapeutics.
- Access up to HK$8 million, to subsidise 50% of expenditure for Class II/III medical devices.
ARE YOU ELIGIBLE TO APPLY FOR CTC FINANCIAL SUPPORT?
This highly selective programme is designed to catalyse the translation of novel and breakthrough technologies and therapies from pre-clinical to the clinical stage. You are eligible to apply for CTC if:
- You are an existing HKSTP company*
- You have at least 3 full-time existing staffers working at your leased premises at HKSTP
- You will remain a HKSTP tenant for the entire term of the funding scheme
- The project coordinator and project team are full-time employees of your company
* Companies which are not HKSTP tenants should first apply for tenancy
TO APPLY
- Contact us now to learn more!
WHO’RE IN OUR PROFESSIONAL NETWORK?
CLINICAL TRIAL CENTRES
CROs, CDMOs, CMOs
Contact Us